Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Statement

10 Dec 2015 07:00

RNS Number : 5796I
PZ CUSSONS PLC
10 December 2015
 

10 December 2015

PZ Cussons Plc

(the "Group")

 

Trading Update

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2015.

 

Overview

 

Group operating profits were broadly flat versus the comparative period with a strong performance in Europe offsetting a difficult trading environment in Nigeria and the impact of weaker currencies in both Asia and Africa.

 

The strength of the Group's innovative product pipeline and the positive impact of new launches are ensuring our market share positions are held or grown in our major markets and categories.

 

Performance in certain categories in Nigeria in the second half is likely to continue to be affected by the ongoing squeeze on consumer disposable income and by the tight environment of foreign exchange liquidity.

 

First half trading

 

Europe

 

In the UK, performance in the washing and bathing division has been strong, driven by a continuous innovation pipeline and the launch of a new range of Carex bodywash products.

 

The beauty division has performed particularly well across its key markets with St Tropez's new in shower gradual tan lotion generating strong sales and the Sanctuary brand benefiting from a new #LetGo campaign as well as the launch of new ranges.

 

Performance in the smaller markets of Poland and Greece was in line with expectations.

 

Asia

 

Despite the challenges of increased costs from weaker exchange rates, reduced consumer disposable income and reduced results on translation to sterling, we have made good progress overall across our Asian markets.

 

In Australia, performance has been good across personal care, beauty and the food & nutrition brands Rafferty's Garden and five:am, whilst trading conditions in the homecare category remain challenging.

 

In Indonesia, revenue growth has continued to be strong despite the more challenging consumer environment as a result of slower GDP growth and a weaker exchange rate.

 

In the smaller Asian markets, Thailand has performed well whilst Middle East performance is marginally lower.

 

Africa

 

In Nigeria, whilst the exchange rate has remained stable against the dollar, low oil prices continue to contribute to an environment of tight liquidity with additional foreign exchange restrictions imposed for certain imported items.

 

Whilst performance in the home and personal care business has been robust despite an extremely competitive environment, revenue and profits in the electricals business are significantly lower as a result of the squeeze on consumer disposable income. Performance in the Nutricima milk business has been strong in the first half. The PZ Wilmar edible oil joint venture has also performed well in the first half although currency liquidity is now beginning to impact the business.

 

In the smaller African markets, Kenya has performed in line with expectations whilst continued currency volatility has affected profitability in Ghana.

 

Full year outlook

 

The strength of the Group's brand portfolio and innovation pipeline continues to ensure that the market shares of our products remain strong in all markets.

 

Performance in Europe and Asia is expected to continue to be robust in the second half.

 

In Nigeria, the home and personal care and milk businesses are expected to continue to perform well. However, if current economic conditions persist, performance in the electricals business during the seasonal second half is expected to be significantly lower and trading in the PZ Wilmar joint venture will be impacted by restrictions on foreign exchange liquidity.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

 

Interim Announcement

 

Interim results for the half year to 30 November 2015 will be announced on Tuesday 26th January 2016.

 

An analysts' presentation will be given at 9:30am on that day at the offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ.

 

- ENDS -

For further information contact:

PZ Cussons Plc

Brandon Leigh - Chief Financial Officer

 

Tel: 0161 435 1236

 

Instinctif

Tim Linacre / Guy Scarborough

 

Tel: 020 7457 2020

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKVBRVSAURAA
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.